CytImmune Sciences' Unattributed - II Round

CytImmune Sciences raised a round of funding on April 15, 2014.

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies. Based on an R&D strategy…

Articles about CytImmune Sciences' Unattributed - II Round: